Initiated sometime during the year 1901 with headquarters located in Jerusalem, Israel, Teva Pharmaceutical Industries was initially established as Salomon, Levin & Elstein Ltd for starting the business as wholesale distributors. But some new migrants from Europe established Teva, Assia and Zori during 1930s. In due course of time, precisely 1951, Teva accumulated additional funds as capital through newly developed Tel-Aviv Stock Exchange.

 

Teva is the global pharmaceutical company which has focused in generic and proprietary pharmaceuticals as well as active pharmaceutical ingredients-APIs. Teva is considered to be the biggest generic medication producer in the world now and is ranked one of the 20 biggest Pharma companies across the world. The consolidated sales proceeds of Teva touched 8.4 billion UDS during the year 2006 of which 80 percent was from the member countries of the European Union and North America.

 

The company has the work force strength of nearly 26,000 employees spanning in around 50 nations across the world, following the takeover of its competitor company Ivax Corporation from the United States during January, 2006. The manufacturing plants of the company are located in Israel, North America, Europe and Latin America. Several more companies were amalgamated in Teva in due course of time which included Ikapharm – the second biggest medicine producer of Israel which gradually made the current Teva Pharmaceutical Industries Ltd one of the largest Pharma enterprises in the world.

 

The major products of Teva Group include: Laquinimod – the Immuno-modulator used as oral therapy like Fingolimod, Copaxone – for treating the multiple sclerosis disorders and Azilect – for treating the indications of Parkinson’s disease.